메뉴 건너뛰기




Volumn 52, Issue 4, 2011, Pages 552-553

Routine follow-up scanning of patients with lymphoma: Who, when, how, and why?

Author keywords

[No Author keywords available]

Indexed keywords

B CELL LYMPHOMA; CANCER RISK; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HODGKIN DISEASE; HUMAN; LYMPHOMA; NONHODGKIN LYMPHOMA; NOTE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; X RAY ANALYSIS;

EID: 79953216032     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.557169     Document Type: Note
Times cited : (4)

References (7)
  • 1
    • 79953214094 scopus 로고    scopus 로고
    • Efficacy ofroutine surveillance with positron emission tomography/computed tomography in aggressive non-Hodgkin lymphoma in complete remission: Status in a single center
    • El-Galaly T, Prakash V, Christiansen I, et al. Efficacy ofroutine surveillance with positron emission tomography/computed tomography in aggressive non-Hodgkin lymphoma in complete remission: status in a single center. Leuk Lymphoma 2011;52: 597-603.
    • (2011) Leuk Lymphoma , vol.52 , pp. 597-603
    • El-Galaly, T.1    Prakash, V.2    Christiansen, I.3
  • 2
    • 64649086758 scopus 로고    scopus 로고
    • Role of [18F]fluorodeox-yglucose positron emission tomography scan in the follow-up of lymphoma
    • Zinzani PL, Stefoni V, Tani M, et al. Role of [18F]fluorodeox-yglucose positron emission tomography scan in the follow-up of lymphoma. J Clin Oncol 2009;27:1781-1787.
    • (2009) J Clin Oncol , vol.27 , pp. 1781-1787
    • Zinzani, P.L.1    Stefoni, V.2    Tani, M.3
  • 3
    • 77953100299 scopus 로고    scopus 로고
    • Role of FDG-PET/CT surveillance for patients with classical Hodgkin's disease in first complete response: The Stanford University experience
    • Abstract 1563
    • Maeda LS, Horning SJ, Iagaru AH, et al. Role of FDG-PET/CT surveillance for patients with classical Hodgkin's disease in first complete response: the Stanford University experience. Blood 2010;114(Suppl. 1): Abstract 1563.
    • (2010) Blood , vol.114 , Issue.SUPPL. 1
    • Maeda, L.S.1    Horning, S.J.2    Iagaru, A.H.3
  • 4
    • 77956810579 scopus 로고    scopus 로고
    • Surveil-lance imaging of Hodgkin lymphoma patients in first remission: A clinical and economic analysis
    • Lee AI, Zuckerman DS, van den Abbeele AD, et al. Surveil-lance imaging of Hodgkin lymphoma patients in first remission: a clinical and economic analysis. Cancer 2010;116:3835-3842.
    • (2010) Cancer , vol.116 , pp. 3835-3842
    • Lee, A.I.1    Zuckerman, D.S.2    Van Den Abbeele, A.D.3
  • 5
    • 0031037135 scopus 로고    scopus 로고
    • Follow up policy after treatment for Hodgkin's disease: Too many clinic visits and routine tests? A review of hospital records
    • Radford JA, Eardley A, Woodman C, Crowther D. Follow up policy after treatment for Hodgkin's disease: too many clinic visits and routine tests? A review of hospital records. BMJ 1997;314:343-346. (Pubitemid 27056556)
    • (1997) British Medical Journal , vol.314 , Issue.7077 , pp. 343-346
    • Radford, J.A.1    Eardley, A.2    Woodman, C.3    Crowther, D.4
  • 6
    • 0037236406 scopus 로고    scopus 로고
    • The role of surveillance CT scans in patients with diffuse large B-cell non-Hodgkin's lymphoma
    • DOI 10.1080/1042819021000040323
    • Guppy AE, Tebbutt NC, Norman A, Cunningham D. The role of surveillance CT scans in patients with diffuse large B-cell non-Hodgkin's lymphoma. LeukLymphoma 2003;44:123-125. (Pubitemid 36113838)
    • (2003) Leukemia and Lymphoma , vol.44 , Issue.1 , pp. 123-125
    • Guppy, A.E.1    Tebbutt, N.C.2    Norman, A.3    Cunningham, D.4
  • 7
    • 77953334559 scopus 로고    scopus 로고
    • Hodgkin's lymphoma in remission after first-line therapy: Which patients need FDG-PET/CT for follow-up?
    • Petrausch U, Samaras P, Veit-Haibach P, et al. Hodgkin's lymphoma in remission after first-line therapy: which patients need FDG-PET/CT for follow-up? Ann Oncol 2010;21:1053-1057.
    • (2010) Ann Oncol , vol.21 , pp. 1053-1057
    • Petrausch, U.1    Samaras, P.2    Veit-Haibach, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.